S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
NASDAQ:CDIO

Cardio Diagnostics (CDIO) Stock Price, News & Analysis

$1.37
+0.02 (+1.48%)
(As of 03/27/2024 ET)
Today's Range
$1.29
$1.40
50-Day Range
$1.24
$2.32
52-Week Range
$0.17
$4.19
Volume
118,452 shs
Average Volume
427,034 shs
Market Capitalization
$28.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Cardio Diagnostics MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.44mentions of Cardio Diagnostics in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.75) to ($0.55) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.47 out of 5 stars

Medical Sector

892nd out of 939 stocks

Diagnostic Substances Industry

13th out of 13 stocks

CDIO stock logo

About Cardio Diagnostics Stock (NASDAQ:CDIO)

Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.

CDIO Stock Price History

CDIO Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Cardio Diagnostics Holdings Inc
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Cardio Climbs on AMA Nod
See More Headlines
Receive CDIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
4/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
NASDAQ:CDIO
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-4,660,000.00
Pretax Margin
-73,893.48%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.45 per share

Miscellaneous

Free Float
14,378,000
Market Cap
$28.14 million
Optionable
Not Optionable
Beta
5.16
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Meeshanthini V. Dogan Ph.D. (Age 35)
    Co-Founder, CEO & Director
    Comp: $433.9k
  • Ms. Elisa Michael Luqman Esq. (Age 60)
    J.D., M.B.A., Chief Financial Officer
    Comp: $175.83k
  • Dr. Robert A. Philibert M.D. (Age 62)
    Ph.D., Co-Founder, Chief Medical Officer & Director
  • Mr. Timur Dogan Ph.D. (Age 36)
    Chief Technology Officer
  • Ms. Khullani Abdullahi J.D. (Age 40)
    Vice President of Revenue & Strategy

CDIO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardio Diagnostics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardio Diagnostics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CDIO shares.
View CDIO analyst ratings
or view top-rated stocks.

How have CDIO shares performed in 2024?

Cardio Diagnostics' stock was trading at $2.49 at the beginning of the year. Since then, CDIO shares have decreased by 45.0% and is now trading at $1.37.
View the best growth stocks for 2024 here
.

Are investors shorting Cardio Diagnostics?

Cardio Diagnostics saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 456,300 shares, a decrease of 7.7% from the February 29th total of 494,300 shares. Based on an average daily volume of 1,230,000 shares, the short-interest ratio is currently 0.4 days. Currently, 2.7% of the shares of the stock are sold short.
View Cardio Diagnostics' Short Interest
.

When is Cardio Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our CDIO earnings forecast
.

Who are Cardio Diagnostics' major shareholders?

Cardio Diagnostics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.13%), Vanguard Group Inc. (1.13%), Northern Trust Corp (0.22%) and Vontobel Holding Ltd. (0.06%). Insiders that own company stock include Meeshanthini Dogan and Robert Philibert.
View institutional ownership trends
.

How do I buy shares of Cardio Diagnostics?

Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CDIO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners